STOCK TITAN

GE HealthCare Technologies (GEHC) DEF 14A Filings

GEHC NASDAQ

Here are the DEF 14A proxy statements from GE HealthCare Technologies Inc. (GEHC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow GEHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GEHC filings page.

Rhea-AI Summary

GE HealthCare Technologies Inc. is asking stockholders to vote at its virtual 2026 annual meeting on May 7, 2026. Holders of 456,290,143 common shares as of March 9, 2026 can vote on three items: electing eight directors for one-year terms, an advisory say‑on‑pay vote on 2025 executive compensation, and ratifying Deloitte & Touche LLP as independent auditor for 2026.

The company highlights 2025 revenue of $20.6 billion, record backlog, and earnings per share growth driven by volume and productivity despite tariff impacts. The board emphasizes strong governance, with seven of eight nominees independent, majority voting, proxy access, no poison pill or dual‑class shares, and a 15‑year director term limit. Executive pay is positioned as performance‑based and long‑term, with rigorous stock ownership requirements, a broad clawback policy, and prohibitions on hedging and pledging.